C-suite changes at Omega Therapeutics and promotions at Cabaletta Bio are among recent executive changes in the industry. Meanwhile, new directors were appointed at AN2 Therapeutics, among others.
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
Flashpoint Therapeutics and Nerviano Medical Sciences (Shanghai) have new leaders, while Genmab hires an ex-Gilead Sciences executive.
Recent moves in the industry include C-suite changes at Galapagos, plus Bristol Myers Squibb gets a new CMO from AstraZeneca.
Recent moves in the industry include changes at the top at Trogenix and Quetzal Therapeutics, plus Synendos Therapeutics gains a new CMO from Roche.
Recent moves in the industry include changes at the top at Ascentage Pharma, Inventiva and Brenig Therapeutics, plus five companies get new CFOs.
François Roger believes fixing inefficiencies is more important than playing with pricing.
Pharma companies like Sarepta, Replimune and Capricor made gains on Wall Street after news broke that the FDA Center for Biologics Evaluation and Research director Vinay Prasad is leaving.
The highlights of recent comments and insights from industry executives on the key issues covered in Scrip.
